Return to homepagePandemic Pact

Neutralising antibodies and protein vaccines

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-175

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Prof. Graham Ogg

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Human Immunology Unit at the University of Oxford

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Defining SARS-CoV-2-specific antibodies isolated from patients and new approaches to vaccination. These will be of value for future therapeutics, diagnostics and disease pathogenesis.